Catherine Leyh

432 total citations
17 papers, 225 citations indexed

About

Catherine Leyh is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Catherine Leyh has authored 17 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in Catherine Leyh's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Mechanisms and Therapy (4 papers) and Liver Disease Diagnosis and Treatment (2 papers). Catherine Leyh is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Mechanisms and Therapy (4 papers) and Liver Disease Diagnosis and Treatment (2 papers). Catherine Leyh collaborates with scholars based in Germany, United States and Netherlands. Catherine Leyh's co-authors include Tom Luedde, Sven H. Loosen, Mihael Vucur, Christian Trautwein, Frank Tacke, Christoph Roderburg, Fabian Benz, Thomas Longerich, Marcel Binnebösel and Tom Florian Ulmer and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Journal of Hepatology.

In The Last Decade

Catherine Leyh

14 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Leyh Germany 6 78 68 64 57 55 17 225
Miho Kawaida Japan 9 88 1.1× 49 0.7× 113 1.8× 100 1.8× 25 0.5× 33 262
Naoki Okura Japan 11 61 0.8× 42 0.6× 92 1.4× 67 1.2× 25 0.5× 20 279
Hironao Okubo Japan 10 79 1.0× 82 1.2× 66 1.0× 54 0.9× 13 0.2× 37 239
Jian‐Guo Hong China 11 158 2.0× 85 1.3× 48 0.8× 45 0.8× 49 0.9× 30 315
Toshinori Hashizume Japan 9 69 0.9× 60 0.9× 81 1.3× 135 2.4× 19 0.3× 34 302
Masaichi Ogawa Japan 10 165 2.1× 35 0.5× 107 1.7× 54 0.9× 51 0.9× 47 284
Aqsa Nasir United States 11 121 1.6× 20 0.3× 73 1.1× 136 2.4× 74 1.3× 24 352
Glen Lo Australia 9 46 0.6× 40 0.6× 16 0.3× 43 0.8× 44 0.8× 26 233
Ines Nikolovski United States 11 22 0.3× 43 0.6× 88 1.4× 100 1.8× 20 0.4× 19 261
Michinori Hamaoka Japan 10 136 1.7× 190 2.8× 77 1.2× 55 1.0× 68 1.2× 38 283

Countries citing papers authored by Catherine Leyh

Since Specialization
Citations

This map shows the geographic impact of Catherine Leyh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Leyh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Leyh more than expected).

Fields of papers citing papers by Catherine Leyh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Leyh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Leyh. The network helps show where Catherine Leyh may publish in the future.

Co-authorship network of co-authors of Catherine Leyh

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Leyh. A scholar is included among the top collaborators of Catherine Leyh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Leyh. Catherine Leyh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Loosen, Sven H., Catherine Leyh, Jennis Kandler, et al.. (2024). Association between Helicobacter pylori and its eradication and the development of cancer. BMJ Open Gastroenterology. 11(1). e001377–e001377. 3 indexed citations
2.
Loosen, Sven H., Markus S. Jördens, Catherine Leyh, et al.. (2024). Long-Term Intake of Proton-Pump Inhibitors Could Be Associated with an Increased Incidence of Liver Cancer in Women. Cancers. 16(8). 1517–1517.
3.
Leyh, Catherine, Jason D. Coombes, Hartmut Schmidt, et al.. (2024). MASLD-Related HCC—Update on Pathogenesis and Current Treatment Options. Journal of Personalized Medicine. 14(4). 370–370. 15 indexed citations
4.
Jördens, Markus S., Christoph Roderburg, Catherine Leyh, et al.. (2024). Elevated HbA1c Levels Are Associated with a Risk of Pancreatic Cancer: A Case–Control Study. Journal of Clinical Medicine. 13(18). 5584–5584.
5.
Jördens, Markus S., et al.. (2024). Evolving therapeutic landscape of advanced biliary tract cancer: from chemotherapy to molecular targets. ESMO Open. 9(10). 103706–103706. 4 indexed citations
6.
Roderburg, Christoph, Sven H. Loosen, Catherine Leyh, et al.. (2024). Temporal Trends in Mental Disorder Rates among Patients with Colorectal Cancer: A Comprehensive Analysis. Journal of Clinical Medicine. 13(13). 3649–3649.
7.
Roderburg, Christoph, Dirk Waldschmidt, Catherine Leyh, et al.. (2024). Associating Appendicitis with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Novel Insight into an Unexpected Connection. Journal of Clinical Medicine. 13(5). 1319–1319. 1 indexed citations
8.
Leyh, Catherine, Christoph Roderburg, Tom Luedde, Sven H. Loosen, & Karel Kostev. (2023). Herpes zoster is not associated with subsequent gastrointestinal cancer: data from over 200,000 outpatients in Germany. Journal of Cancer Research and Clinical Oncology. 149(19). 17115–17121. 1 indexed citations
9.
Roderburg, Christoph, Sven H. Loosen, Catherine Leyh, et al.. (2023). Prevalence of and factors associated with a treatment delay due to the COVID-19 pandemic in patients with gastrointestinal cancer in Europe. Journal of Cancer Research and Clinical Oncology. 149(13). 11849–11856. 3 indexed citations
10.
Loosen, Sven H., Andreas Krieg, Catherine Leyh, et al.. (2023). Are sleep disorders associated with the risk of gastrointestinal cancer?—A case–control study. Journal of Cancer Research and Clinical Oncology. 149(13). 11369–11378. 7 indexed citations
12.
Leyh, Catherine, Ursula Ehmer, Daniel Roessler, et al.. (2022). Sorafenib Versus Lenvatinib-Based Sequential Systemic Therapy for Advanced Hepatocellular Carcinoma: A Real-World Analysis. Cancers. 14(8). 1975–1975. 4 indexed citations
13.
Hirmas, Nader, Catherine Leyh, Miriam Sraieb, et al.. (2021). 68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma. Journal of Nuclear Medicine. 62(9). 1235–1241. 52 indexed citations
14.
Finkelmeier, Fabian, Bernhard Scheiner, Catherine Leyh, et al.. (2020). Cabozantinib in advanced hepatocellular carcinoma: Efficacy and safety data from an international multicenter real-world cohort.. Journal of Clinical Oncology. 38(15_suppl). e16668–e16668. 5 indexed citations
15.
Loosen, Sven H., Maximilian Schulze‐Hagen, Catherine Leyh, et al.. (2018). IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies. International Journal of Molecular Sciences. 19(6). 1766–1766. 38 indexed citations
16.
Loosen, Sven H., Frank Tacke, Marcel Binnebösel, et al.. (2018). Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases. Oncotarget. 9(43). 27027–27038. 20 indexed citations
17.
Loosen, Sven H., Christoph Roderburg, Catherine Leyh, et al.. (2017). Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma. Journal of Hepatology. 67(4). 749–757. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026